Agreya Multi-Asset Enhancer PMS Review: Performance, Fees & Is It Worth the Cost?
| What Works | What Doesn’t |
|---|---|
| Genuinely distinctive mandate — mostly non-equity instruments with a tactical call-option overlay for equity upside, rather than a plain-vanilla equity book | 3-year net return (10.34%) and 1-year net return (7.41%) both trail the regular-plan active Multi Asset Allocation mutual fund category average |
| Strong since-inception track record (14.36% vs. the benchmark’s 11.09%) over a full 7-year cycle | Fee load (2% fixed, or a lower fixed fee plus 20% profit share above a 10% hurdle) is steep for a strategy that holds a majority of assets in non-equity instruments |
| Genuinely alternative return stream — an options-overlay approach most retail mutual funds don’t replicate | No SIP or STP facility, limiting how you can build into or out of the position |
| Backed by an experienced, process-driven Co-CIO with a systematic, testable approach to strategy design | Small AUM (₹75.38 crore) after 7 years may point to limited investor uptake at scale |
| Nil exit load through the first three years | Portfolio-level transparency (holdings, sectors, market-cap mix) isn’t published anywhere we could independently verify |
Verdict: Agreya Multi-Asset Enhancer has a genuinely different playbook — the bulk of the portfolio sits outside equities, with tactical option buying used to participate in market upside.
That differentiation is real, and it’s shown up in a strong since-inception number.
But on the trailing periods that matter most for a decision you’re making today — 1 year, 3 years — the net return has fallen short of what a comparable active mutual fund in the same category has delivered, at a meaningfully lower cost.
A distinctive strategy still has to clear the same bar as everything else in your portfolio: return net of fee, not just return.
The PMS Value Framework
Before we go further, here is the lens we use for every PMS review:
Gross Alpha > Fee = Value Added | Gross Alpha ≈ Fee = Break-Even | Gross Alpha < Fee = Value Destroyed
Where does Multi-Asset Enhancer sit?
Its disclosed returns are net of all fees. Over 1 year and 3 years, that net number trails the regular-plan active Multi Asset Allocation category average by a meaningful margin — roughly 2.5–3 percentage points — despite a fee structure that runs comfortably higher than what a typical multi-asset mutual fund charges.
This leans the strategy toward the Value Destroyed side of Break-Even on a trailing basis: the fee here is currently costing you more than the strategy is adding relative to a lower-cost, comparable alternative.
The since-inception number tells a better story, and we’ll get to why that gap between “since inception” and “trailing” matters.
2. Who This PMS May Still Suit
3. Who Should Likely Avoid This PMS
4. What Is Agreya Multi-Asset Enhancer?
7. The Zero-Based Thinking Test
10. The Core Portfolio Architecture Question
11. What a Genuinely Complementary PMS Looks Like
| Key Fact | Detail |
|---|---|
| PMS Name | Agreya Multi-Asset Enhancer |
| AMC | Agreya Capital Advisors LLP |
| Category | PMS – Multi Asset |
| Fund Manager | Mr. Arjun Narsipur, Co-CIO and Fund Manager (14 years of experience across equity, FX, global markets, and treasury risk management) |
| Inception Date | 4 June 2019 |
| Portfolio Age | 7 years, 0 months |
| Benchmark | NSE Multi Asset Index 1 |
| AUM | ₹75.38 crore |
| Minimum Investment | ₹50,00,000 |
| SIP / STP | Not available |
Mandate promise vs. data reality: The stated investment approach is to place the majority of assets into non-equity instruments and, at opportune moments, hedge that positioning by buying call options on the indices — with an explicit objective of generating “better risk-adjusted return over the benchmark.”
That’s a meaningfully different mandate from a typical equity PMS: this is closer to a capital-preservation-first approach with tactical, options-based participation in market upside, run by a Co-CIO whose stated focus is converting investment philosophies into testable, repeatable, algorithmic processes.
Two things worth flagging plainly. First, because the objective is explicitly framed around risk-adjusted return, a fair verdict really needs volatility and drawdown data (Sharpe ratio, maximum drawdown) alongside raw CAGR — and that isn’t published anywhere we could independently access.
That’s not a mark against the AMC; portfolio managers routinely share this kind of granular risk data directly with prospective and existing investors rather than on public listings, and it’s worth asking for before you commit or continue.
Second, top holdings, sector allocation, and market-cap composition are also not published on this portal — again, standard practice for the AMC to share directly with clients on request rather than a governance concern, and in this specific case arguably less critical than usual, since a strategy that’s majority non-equity with an options overlay doesn’t lend itself to a traditional stock-level or market-cap breakdown the way an equity PMS would.
AMC background: Agreya Capital Advisors LLP is a SEBI-registered portfolio manager offering both discretionary and non-discretionary services.
The firm has mandated the Edelweiss Group for custody, fund accounting, and broking services — a reasonable institutional-backing signal for operational due diligence.
Agreya also runs a large-cap strategy (Momentum) and two multi-cap/flexi-cap strategies (including Total Return Enhancer) alongside this one.
Trailing Returns vs. Benchmark (as of 30th June 2026)
| Period | Multi-Asset Enhancer (Net) | NSE Multi Asset Index 1 | Alpha (+/-) |
|---|---|---|---|
| 1 Month | 1.14% | 1.49% | -0.35% |
| 3 Months | 4.03% | 7.36% | -3.33% |
| 6 Months | 1.33% | 0.44% | +0.89% |
| 1 Year | 7.41% | 3.57% | +3.84% |
| 2 Years | 3.99% | 5.84% | -1.85% |
| 3 Years | 10.34% | 11.41% | -1.07% |
| 5 Years | 10.81% | 10.31% | +0.50% |
| Since Inception | 14.36% | 11.09% | +3.27% |
The honest read here is: mixed, and more volatile from one period to the next than the strategy’s “capital preservation with optionality” framing might suggest.
The 1-year alpha (+3.84%) and the since-inception alpha (+3.27%) are genuinely strong.
But the 3-month, 2-year, and 3-year numbers all show the strategy behind its own benchmark — which is a wider spread of outcomes than you’d expect from a mandate built around downside protection.
But wait — look at this more carefully. A benchmark comparison only tells you whether the manager beat a passive yardstick — it doesn’t tell you whether the strategy beat the realistic alternative available to you.
That’s an actively managed Multi Asset Allocation mutual fund, held through a regular plan the way most investors actually hold one.
On that basis, using the category average (not a top-quartile fund), the picture turns more clearly unfavourable: the category has delivered roughly 10.1% over 1 year and roughly 13.2% over 3 years, on a regular-plan basis — both comfortably ahead of Multi-Asset Enhancer’s 7.41% and 10.34% over the same periods.
At 5 years, the category average (roughly 12.4%) is also ahead of the PMS’s 10.81%.
One important caveat, in fairness to the strategy: mutual fund Multi Asset Allocation categories typically hold real exposure to equities, debt, and gold — and gold has had an exceptional run recently, which has meaningfully lifted category-average returns industry-wide.
Agreya’s stated approach — majority non-equity instruments plus a call-option overlay — doesn’t appear to include a gold allocation, so part of this gap may reflect the category benefiting from an asset class this strategy simply doesn’t hold, rather than a like-for-like skill gap.
That’s a real nuance, not an excuse — but it means the comparison, while still the most relevant one available, is not perfectly apples-to-apples.
Fee Structure
| Component | Detail |
|---|---|
| Fixed Fee Option | 2.00% per annum (AMC fee) |
| Fixed + Performance Option | 1.20% fixed fee, plus 20% profit sharing above a 10% hurdle rate |
| Exit Load | Nil in Year 1, Year 2, and Year 3 |
| Minimum Investment | ₹50,00,000 |
A 2% flat fee — or a 20% profit share above a 10% hurdle — is a fully-loaded, equity-PMS-grade fee structure.
That’s a notable ask for a strategy that places the majority of its assets in non-equity instruments; the return-generating engine here is meant to be more conservative than a concentrated equity book, and the fee should, in a fair world, reflect that.
Instead, it sits at the same level many pure-equity PMS strategies charge. That mismatch is worth sitting with on its own, independent of the return numbers.
Fee Drag on ₹50 Lakhs: The Rupee Picture
Assumption: returns held constant at the current trailing 5-year net CAGR for illustration. Active mutual fund figure uses the Multi Asset Allocation category average return, net of a typical regular-plan expense ratio — the plan most investors actually hold, distribution costs included — not a top-quartile fund.
| Scenario | Return Assumption (Net, Trailing 5-Yr CAGR) | Corpus After 5 Years | Corpus After 7 Years |
|---|---|---|---|
| Agreya Multi-Asset Enhancer (Net) | 10.81% | ₹83.52 lakh | ₹1.03 crore |
| Active Mutual Fund – Multi Asset Allocation Category Average, Regular Plan (Net) | 12.40% | ₹89.70 lakh | ₹1.13 crore |
The gap — roughly ₹6.2 lakh at 5 years and ₹10.8 lakh at 7 years on a ₹50 lakh investment — is not a rounding error.
It’s a meaningful, compounding cost of choosing this specific structure over a lower-cost, comparable active mutual fund, and it’s the single clearest number in this entire review.
Even accounting for the gold-driven tailwind caveat above, a gap this size deserves a direct conversation with the fund manager about what’s driving it before you add another rupee.
Here’s the question that matters more than any return table: Knowing everything you know today, if you were starting fresh with this ₹50 lakh, would you invest in this exact product?
Not “should I sell because I’m disappointed.” Not “should I hold because I’ve already committed capital and seven years of patience to it.”
Just — stripped of the sunk cost, stripped of the loyalty to a decision you made in 2019 — would you sign this same contract today?
Seven years is a genuinely long track record for a PMS, and it covers a real market cycle — including a strong CY19–21 stretch, a tougher CY22, and a recovery since.
The since-inception alpha (+3.27% over the benchmark) is a legitimate point in the strategy’s favour, earned over real time, not backtested.
But notice what the trailing numbers are telling you: the more recent 1-year, 2-year, and 3-year windows look meaningfully weaker relative to both the benchmark and the active mutual fund alternative than the since-inception number suggests.
A long, strong average can mask a recent stretch that, judged on its own, wouldn’t clear the bar you’d apply to a fresh decision today.
Staying invested simply because you already are being not a neutral choice — it’s a decision, and one that deserves the same scrutiny you’d apply to a fresh commitment.
If the honest answer to the zero-based question is “no, not at this fee, not against what’s now available” — that tells you something, regardless of how good the first few years were.
If it’s “yes, I specifically want this hedged, options-based approach and I’m comfortable paying for it” — that’s a legitimate answer too.
This review isn’t here to talk you out of either conclusion.
It’s here to make sure you’re answering the real question, not the comfortable one.
| Decision Factor | Rating | Analysis |
|---|---|---|
| Uniqueness vs. existing MF/asset-allocation portfolio | 🟢 | A majority-non-equity book with a tactical call-option overlay is a genuinely different return stream from a standard equity, hybrid, or even most multi-asset mutual funds, which typically hold direct equity, debt, and gold rather than an options-based upside mechanism. If your portfolio is otherwise all long-only funds, this is a real diversifier in structure, even where the fee case is weak. |
| Alpha consistency across all periods | 🔴 | Alpha versus the benchmark is inconsistent — meaningfully positive at 1 year and since inception, but negative at 3 months, 2 years, and 3 years. For a mandate built around risk-adjusted, downside-aware returns, this degree of period-to-period variability against its own benchmark is a real inconsistency to flag, not just noise. |
| Justification for PMS premium fee | 🔴 | This is the crux of the review. Net-of-fee returns trail the regular-plan Multi Asset Allocation category average at 1, 3, and 5 years by a meaningful margin, while the fee (2% fixed, or 1.20% plus a 20% profit share) is priced like a full equity PMS despite a majority non-equity mandate. The gold-tailwind caveat softens but doesn’t erase this gap. |
| Downside/capital-preservation orientation | 🟡 | The stated approach — majority non-equity, tactical option buying rather than full equity exposure — is structurally built for capital preservation. But without disclosed drawdown or volatility data, we can’t independently verify that this translated into a smoother ride than the benchmark; the negative 6-month figure and negative 2-year and 3-year alpha suggest it hasn’t been friction-free. |
| Portfolio complement for existing MF investor | 🟡 | If you already hold a multi-asset or balanced-advantage mutual fund, this PMS is solving a similar allocation problem through a different mechanism (options overlay vs. direct multi-asset holdings) — genuinely different in structure, but the practical question of whether it adds enough beyond what you already have depends entirely on your existing portfolio and is worth a direct look rather than an assumption either way. |
| Mandate purity and discipline | 🟢 | The strategy has stuck to its stated non-equity-plus-options framing over a full 7-year cycle rather than drifting into a conventional equity book, and the fund manager’s stated focus on testable, repeatable, algorithmic processes suggests a disciplined, rules-based approach rather than ad hoc discretion. |
| Fund manager transparency | 🟡 | Arjun Narsipur’s background (14 years across equity, FX, global markets, and treasury risk management) is disclosed, but the public profile doesn’t specify exactly when he began managing this particular strategy relative to its 2019 inception — worth confirming directly rather than assuming continuity. |
| Investment horizon suitability | 🟡 | The strategy has rewarded a full 7-year hold with a strong since-inception number, but the more recent 1–3 year stretch has been weaker on a relative basis — meaning horizon alone hasn’t been a guarantee of outperformance in every recent window. |
| Asset-class flexibility utilisation | 🟢 | The mandate’s flexibility to sit predominantly outside equities and use options tactically is genuinely being used as described, not just stated — this isn’t a disguised equity fund. |
| Portfolio-level transparency | 🟡 | Top holdings, sector mix, and instrument-level composition aren’t published on the portal we reviewed. Given the strategy’s non-equity, options-based nature, a traditional equity-style breakdown may be less applicable anyway — but for an investor writing a ₹50 lakh cheque, getting this detail directly from the manager before committing is still worth doing. |
| AUM size and strategy capacity | 🟡 | At ₹75.38 crore after 7 years, AUM is modest. That’s not disqualifying — smaller AUM can mean more nimble execution for a tactical, options-driven approach — but it’s also consistent with limited investor uptake at scale over a fairly long track record, which is worth asking the manager about directly. |
| Manager tenure and continuity risk | 🟡 | Arjun Narsipur is the named Co-CIO and Fund Manager today, with 14 years of broader experience, but continuous tenure specifically on this strategy since its 2019 inception isn’t explicitly confirmed in the public profile — a reasonable question to raise before committing fresh capital. |
| Liquidity and accessibility features | 🔴 | No SIP or STP facility means you’re committing the full ₹50 lakh minimum in one go, and exiting the same way — less flexibility than either a mutual fund or several other PMS strategies offer for phasing in or out of a position. |
| Decision Factor | Rating |
|---|---|
| Uniqueness vs. existing MF/asset-allocation portfolio | 🟢 Pass |
| Alpha consistency across all periods | 🔴 Concern |
| Justification for PMS premium fee | 🔴 Concern |
| Downside/capital-preservation orientation | 🟡 Mixed |
| Portfolio complement for existing MF investor | 🟡 Mixed |
| Mandate purity and discipline | 🟢 Pass |
| Fund manager transparency | 🟡 Mixed |
| Investment horizon suitability | 🟡 Mixed |
| Asset-class flexibility utilisation | 🟢 Pass |
| Portfolio-level transparency | 🟡 Mixed |
| AUM size and strategy capacity | 🟡 Mixed |
| Manager tenure and continuity risk | 🟡 Mixed |
| Liquidity and accessibility features | 🔴 Concern |
Every portfolio decision eventually comes back to one structural question: what job is this piece of capital actually doing for you?
A well-built portfolio typically separates into a core — low-cost, diversified, doing the heavy lifting of long-term compounding — and a satellite — selective, higher-conviction positions that access something the core structurally cannot.
A multi-asset PMS like this one earns its satellite place only if the options-overlay mechanism is genuinely adding something your existing asset-allocation fund or hybrid mutual fund can’t replicate — not simply because “multi-asset” sounds diversified.
If you already own a multi-asset allocation or balanced-advantage mutual fund doing a similar job of blending equity, debt, and tactical positioning, ask directly: is this PMS’s return stream meaningfully uncorrelated with that fund, or is it just a costlier way of expressing a similar view?
If you decide a PMS still has a role in your portfolio, here’s the general bar we’d hold any strategy to, this one included:
We’re not naming a specific alternative here — that’s not the point of this review, and it isn’t our role to sell you the next product.
The point is to give you a standard to hold any PMS to, including this one.
i. Is Agreya Multi-Asset Enhancer a good PMS to invest in?
Agreya Multi-Asset Enhancer PMS has a genuinely distinctive, non-equity-plus-options approach and a strong since-inception number, but it’s more recent trailing returns (1, 3, and 5 years) have lagged a comparable active mutual fund category average, despite a fee structure priced like a full equity PMS. Whether it’s “good” depends heavily on what specific gap in your portfolio you’re trying to fill.
ii. What is the minimum investment for Agreya Multi-Asset Enhancer? ₹50,00,000 (₹50 lakhs).
iii. What are Agreya Multi-Asset Enhancer’s returns?
As of 30 June 2026: 1-year 7.41%, 2-year 3.99%, 3-year 10.34%, 5-year 10.81%, and since inception 14.36% (annualised beyond 1 year).
iv. What are the fees on Agreya Multi-Asset Enhancer?
Agreya Multi-Asset Enhancer PMS has a fixed fee of 2.00% per annum, or a lower fixed fee of 1.20% combined with a 20% profit share above a 10% hurdle rate, depending on the option chosen.
v. Who manages Agreya Multi-Asset Enhancer?
Mr. Arjun Narsipur, Co-CIO and Fund Manager at Agreya Capital Advisors LLP, with 14 years of experience across equity, FX, global markets, and treasury risk management.
vi. How is this different from a multi-asset allocation mutual fund?
Most multi-asset mutual funds hold direct exposure to equity, debt, and often gold. This PMS instead holds a majority of assets in non-equity instruments and uses call options on indices to tactically participate in equity upside — a structurally different mechanism, even when the broad “multi-asset” label sounds similar.
vii. Can I invest via SIP in this PMS?
No — SIP and STP facilities are not available for this strategy; investment is via a lump sum minimum of ₹50 lakhs.
viii. How is a PMS taxed compared to a mutual fund?
A PMS holds instruments directly in your name, so each instrument sold is a separate capital gains event, and derivative instruments such as index call options are typically taxed differently from listed equity — making PMS taxation meaningfully more involved than a single mutual fund redemption.
ix. How do I know if this PMS overlaps with my existing mutual funds? Compare its structural approach and disclosed returns against any multi-asset, hybrid, or balanced-advantage mutual funds you already hold. If you’d rather not do this analysis alone, this is exactly the kind of review we can help you with.
We do work with select PMS strategies as part of a core-satellite portfolio — but Agreya Multi-Asset Enhancer isn’t currently one we recommend to our clients, for the reasons laid out above.
If you already hold this PMS, or are considering it, and want an independent, CFP-led look at how it actually sits alongside your existing mutual fund and asset-allocation holdings — where it genuinely complements them, and where it simply overlaps — you’re welcome to book a complimentary portfolio review with us.
Listen to this article Quick Summary What Works What Doesn't Experienced fund management leadership with…
Listen to this article Quick Summary What Works What Doesn't Strong 3-month and 5-year-plus numbers,…
Listen to this article Can the HDFC Life Click 2 Invest Plus help you achieve…
Listen to this article Quick Summary What Works What Doesn't Genuine micro-cap and small-cap mandate…
Listen to this article Quick Summary What Works What Doesn't A genuinely different investment process…
Listen to this article Quick Summary What Works What Doesn't One of the longest live…